Atara Biotherapeutics, Inc.
ATRANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $129.13M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.92$19.15
- Volume (live)
- -
- Avg. volume (3M)
- 37.18K
Atara Biotherapeutics (ATRA) Stock Price & Financial Analysis
Atara Biotherapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.55 - $9.37 |
|---|---|
| 52-Week High | $19.15 |
| 52-Week Low | $3.92 |
| Open | $9.37 |
| Volume (last close) | 24.27K |
| Average Volume (3M) | 37.18K |
| Revenue (TTM) | 6.19M |
|---|---|
| Net Income (TTM) | -16.69M |
| Free Cash Flow (TTM) | -21.89M |
| EPS (TTM) | −$1.21 |
| Profit Margin | -269.42% |
| Operating Margin | -229.67% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 129.13M |
|---|---|
| Shares Outstanding | 15.03M |
| Price to Sales (P/S) | 20.85 |
| Price to Book (P/B) | -3.49 |
| EV/EBITDA | -10.83 |
| 50-Day MA | $9.23 |
|---|---|
| 200-Day MA | $7.79 |
| 1-Year Change | −33.22% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Atara Biotherapeutics at a Glance
As of the Oct 23, 2026 close, Atara Biotherapeutics (ATRA) has a market capitalization of $129.13M. The stock trades at 20.9× sales. Over the trailing twelve months it lost $16.69M on revenue of $6.19M and burned $21.89M of free cash flow. Revenue fell 96.7% year over year.
As of its latest reported balance sheet, it holds $3.22M in cash and securities against $9.88M of debt, a net debt position of $6.66M.
Atara Biotherapeutics does not currently pay a dividend.
The share price is down 33.2% over the past year. At $8.59 (the Oct 23, 2026 close) it sits within its 52-week range of $3.92 to $19.14, above its 200-day moving average of $7.79.
Frequently Asked Questions About Atara Biotherapeutics
What is the current stock price for ATRA?
As of the Oct 23, 2026 close, ATRA stock trades at $8.59. The 52-week range is $3.92–$19.15, with a day range of $8.55–$9.37.
What is the P/E ratio for ATRA?
The P/E ratio (Price-to-Earnings) for ATRA is shown in the Key Statistics section. This valuation metric helps compare Atara Biotherapeutics, Inc. to industry peers.
Does ATRA pay dividends?
Atara Biotherapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ATRA?
Analyst ratings and recommendations for ATRA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ATRA?
As of the Oct 23, 2026 close, Atara Biotherapeutics's market capitalization is $129.1M, classifying it as a micro-cap company. Atara Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.